IP Verse

Adare I competitive analysis

Loading summary...

Latest patents of Adare I opposed by its competitors

Explore Adare I's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3041476	Jan 25, 2023	Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis	1
EP3403654	Jul 31, 2019	Orally Administered Corticosteroid Compositions	1
EP2482822	Aug 1, 2018	Orally Administered Corticosteroid Compositions	1

Latest publications and patents of Adare I New

Explore the latest publications and patents granted to Adare I, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Adare I
EP3041476	Jan 25, 2023	Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis	Patent Maintained As Amended
EP3403654	Jul 31, 2019	Orally Administered Corticosteroid Compositions	Granted And Under Opposition
EP2482822	Aug 1, 2018	Orally Administered Corticosteroid Compositions	Revoked

Latest PTAB cases involving Adare I

Discover the latest PTAB cases involving Adare I, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Adare I with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
ADARE I	-	3	-	-
DR FALK PHARMA	10	2	6	-